Page 27 - Irish Office News Today : Breaking News, Live Updates & Top Stories | Vimarsana

Perrigo Reports First Quarter 2021 Financial Results From Continuing Operations Consumer Transformation Nearing Completion Ahead of Schedule Rx Transaction On-Track to Close in Q3 21; Rx Segment Now Reported in Discontinued Operations 2021 Guidance Reaffirmed Share this article Share this article DUBLIN, May 11, 2021 /PRNewswire/  Perrigo Company plc (NYSE; TASE: PRGO), a leading global provider of Consumer Self-Care Products, today announced financial results from continuing operations for the first quarter of fiscal year 2021 ended April 3, 2021. The Consumer Self-Care Americas ( CSCA ) segment, the Consumer Self-Care International ( CSCI ) segment and Corporate are included in results from continuing operations. Financial results from the generic Rx pharmaceuticals business are reported as discontinued operations. All comparisons are against the prior-year fiscal first quarter, unless otherwise noted.

United statesMurrays kesslerDigestive healthRosemont pharmaceuticalsCare internationalCompany formExchange commissionWhile the companyCare international segmentPerrigo companyUs internal revenue serviceConsumer self care productsConsumer self care americasConsumer self care internationalConsolidated statementsBalance sheets